Last reviewed · How we verify
NCT06381206
Silodosin in Management of Lower Ureteral Stones
Phase 1, PHASE2 trial testing Silodosin in Stone, Kidney in 100 participants. Completed in 25 October 2023.
20 October 2023
Quick facts
| Lead sponsor | Syrian Private University |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 20 October 2022 |
| Primary completion | 20 October 2023 |
| Estimated completion | 25 October 2023 |
| Sites | 1 location across Syria |
Drugs / interventions tested
- Silodosin (SILODOSIN) — full drug profile →
Conditions studied
- Stone, Kidney — all drugs for Stone, Kidney →
Sponsor
Syrian Private University
Who can join
20 and older, any sex, with Stone, Kidney. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research aims to study the effectiveness of silodosin in the management of lower ureter stones larger than 6 mm in diameter in terms of affected ureter (right or left), the size of the stone, the degree of hydronephrosis, the rate of stone expulsion(day), whether the stone was completely expelled or not, and the side effects of silodosin.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06381206
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Silodosin
Trials testing the same drug.
- NCT07467343 — Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial · Phase 4 · not yet recruiting
- NCT06114979 — Silodosin vs Placebo in the Treatment of Female LUTS · Phase 3 · unknown
- NCT06999135 — Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones · NA · completed
- NCT05790902 — COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI · Phase 1 · completed
- NCT07134907 — The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH · Phase 4 · completed
Other recruiting trials for Stone, Kidney
Currently open trials in the same condition.
- NCT07306819 — Comparison Between Two Methods for Renal Stone Treatment Mini Percutaneous Nephrolithotomy and Flexible Ureteroscopy Wit · NA · recruiting
- NCT07052188 — Effect of Preop Stent Duration on SFR and Secondary Intervention in RIRS · NA · active not recruiting
- NCT06860113 — Evaluation of Retrograde Intra Renal Surgery in the T-tilted Position · NA · recruiting
- NCT07068087 — Silodosin in Facilitating Flexible Uretroscopy · NA · active not recruiting
- NCT06797466 — Three Dimensional Virtual Reconstruction (3D) in Percutaneous Nephrolithotomy · NA · recruiting
Other Syrian Private University trials
Trials by the same sponsor.
- NCT06190938 — Diabetes Complications and Hearing Loss · completed
- NCT06328595 — Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria · completed
- NCT06219603 — Knowledge and Awareness About Inflammatory Articular Diseases · completed
- NCT06134726 — Temporomandibular Joint in Patients With Rheumatoid Arthritis · completed
- NCT06228911 — Increased Blood Glucose Levels After Steroid Injection · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06381206 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Syrian Private University
- Last refreshed: 24 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06381206.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing